Original Articles
V. 66 N. 4 (2017)
Il dibattito in Bioetica - I nuovi farmaci per l'HCV: una possibile "lezione metodologica" / The debate in Bioethics. The new drugs for HCV: a possible "methodological lesson"
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
##plugins.generic.dates.received##: 11 ottobre 2017
##plugins.generic.dates.accepted##: 11 ottobre 2017
##plugins.generic.dates.accepted##: 11 ottobre 2017
871
Visite
20
Downloads
Autori
Downloads
La data di download non è ancora disponibile.
Citations
Come citare
Il dibattito in Bioetica - I nuovi farmaci per l’HCV: una possibile "lezione metodologica" / The debate in Bioethics. The new drugs for HCV: a possible "methodological lesson". (2017). Medicina E Morale, 66(4), 533-537. https://doi.org/10.4081/mem.2017.505